Five 10% shareholders of V2X, Inc. sold 2.5 million shares for approximately $173.6 million on March 12, 2026, representing 55.94% of their holdings. Despite the large insider sale, the company remains strong with adjusted earnings up 20% in 2025 and a major $4.6 billion U.S. military contract through 2034. The stock has outperformed the S&P 500 by 25% year-to-date.

V2X Inc., a smaller defense contractor, has secured a significant $4.3 billion Air Force contract and demonstrated strong financial performance, with 60% year-over-year improvement in adjusted earnings per share and a growing military services backlog.

V2X, a small defense company formed from the merger of Vectrus and Vertex Aerospace, has secured two significant Pentagon contracts totaling $8 billion over two years. Despite impressive contract wins, the company's current profitability remains modest, with analysts predicting potential future growth.

NATO allies agreed to gradually increase defense spending to 5% by 2035, potentially triggering a decade-long arms race. Three defense industry stocks show promising growth potential amid this commitment.

V2X Inc. has secured a $170 million contract from the Drug Enforcement Administration (DEA) to support its fleet of over 100 aircraft, bolstering the agency's efforts to combat drug trafficking and safeguard national security.

V2X, an integrated defense company, has been awarded a $3.7 billion contract by the U.S. Army to provide 'readiness capabilities' and 'mission enablement services' for the Army's training aids, devices, simulations, and simulators over a five-year period.

V2X (VVX) delivered earnings and revenue surprises of 20% and 4.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Riot Platforms, Inc. (RIOT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

U.S. stock markets closed higher after two days of decline.

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. Shares of NIO Inc. (NYSE: NIO) rose during Tuesday’s session following upbeat quarterly results. NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter. Analysts, on average, estimated revenue of $2.29 billion for the quarter. Excluding share-based compensation expenses, the company reported an adjusted loss of (2.81) yuan or ($0.39) compared to (3.07) yuan in the year-ago quarter and (2.28) yuan in the third quarter of 2023. Analysts had called for a loss of $(0.51) per share. NIO shares gained 3.6% to $5.52 on Tuesday. Here are some other big stocks recording gains in today’s session. Apogee Therapeutics, Inc. (NASDAQ: APGE) shares gained 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results. Dave ...

V2X (VVX) delivered earnings and revenue surprises of 14.02% and 3.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Elastic (ESTC) delivered earnings and revenue surprises of 16.13% and 2.33%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?